CULLINAN ONCOLOGY INC's ticker is CGEM and the CUSIP is 230031106. A total of 98 filers reported holding CULLINAN ONCOLOGY INC in Q4 2022. The put-call ratio across all filers is 0.25 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $295,320 | +353.8% | 32,632 | +439.6% | 0.00% | – |
| Q2 2023 | $65,076 | -63.8% | 6,048 | -56.8% | 0.00% | -100.0% |
| Q3 2022 | $180,000 | -86.8% | 14,015 | -86.9% | 0.00% | -87.5% |
| Q2 2022 | $1,368,000 | +739.3% | 106,690 | +587.2% | 0.01% | +700.0% |
| Q1 2022 | $163,000 | -11.4% | 15,526 | +30.3% | 0.00% | -50.0% |
| Q4 2021 | $184,000 | – | 11,916 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| MPM BioImpact LLC | 7,648,268 | $98,051,000 | 27.24% |
| CHI Advisors LLC | 3,047,609 | $39,070,000 | 14.92% |
| Nextech Invest Ltd. | 1,221,145 | $15,655,000 | 5.28% |
| BVF INC/IL | 7,509,059 | $96,266,000 | 4.65% |
| TANG CAPITAL MANAGEMENT LLC | 609,231 | $7,810,000 | 1.18% |
| Boxer Capital, LLC | 1,074,082 | $13,770,000 | 0.87% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 213,090 | $2,732,000 | 0.84% |
| Atom Investors LP | 96,880 | $1,242,000 | 0.54% |
| EcoR1 Capital, LLC | 1,169,889 | $14,998,000 | 0.52% |
| Birchview Capital, LP | 45,114 | $578,000 | 0.42% |